Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yakoub-Agha, Ibrahim  [Clear All Filters]
2019
Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
Fayard, A., Daguenet, E., Blaise, D., Chevallier, P., Labussière, H., Berceanu, A., Yakoub-Agha, I., Socié, G., Charbonnier, A., Suarez, F., et al. (2019). Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell.Bone Marrow Transplant.
Bazarbachi, A., Boumendil, A., Finel, H., Castagna, L., Dominietto, A., Blaise, D., Diez-Martin, J.L., Tischer, J., Gulbas, Z., Wallet, H.L., et al. (2019). Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.Br J Haematol.
Hayashi, H., Volt, F., Sanz, J., Petersen, E., Dhedin, N., Hough, R., Milpied, N., Angelucci, E., Yakoub-Agha, I., Michallet, M., et al. (2019). Myeloablative unrelated cord blood transplantation in adolescents and young adults with acute leukemia.Biol Blood Marrow Transplant.
Gagelmann, N., Eikema, D.-J., Koster, L., Caillot, D., Pioltelli, P., Lleonart, J.Bargay, Reményi, P., Blaise, D., Schaap, N., Trneny, M., et al. (2019). Tandem autologous stem cell transplantation improves outcome in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the Chronic Malignancies Working Party of EBMT.Biol Blood Marrow Transplant.
2018
Bazarbachi, A., Boumendil, A., Finel, H., Mohty, M., Castagna, L., Blaise, D., Peggs, K.S., Afanasyev, B., Díez-Martín, J.L., Corradini, P., et al. (2018). Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.Cancer.
Lee, C.J., Labopin, M., Beelen, D., Finke, J., Blaise, D., Ganser, A., Itälä-Remes, M., Chevallier, P., Labussière-Wallet, H., Maertens, J., et al. (2018). Comparative Outcomes of Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Acute Myeloid Leukemia with Prior Solid Tumor: a report from the ALWP of the EBMT.Am J Hematol.
Cornillon, J., Detrait, M., Karam, M., Le Bars, L., Meziane, Y., Pereira, M., Richard-Leveille, S., Marion, S., Leroux, S., Coiteux, V., et al. (2018). [Harmonization of data coding in post-transplant follow-up - "GVHD, complications and additional treatments": Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].Bull Cancer.
Robin, M., Porcher, R., Ruggeri, A., Blaise, D., Wolschke, C., Koster, L., Angelucci, E., Stölzel, F., Potter, V., Yakoub-Agha, I., et al. (2018). HLA mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis.Biol Blood Marrow Transplant.
Gilleece, M.H., Labopin, M., Yakoub-Agha, I., Volin, L., Socié, G., Ljungman, P., Huynh, A., Deconinck, E., Wu, D., Bourhis, J.Henri, et al. (2018). Measurable residual disease, conditioning regimen intensity and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: a registry analysis of 2292 patients by the Acute Leukemia Working Party Eu.Am J Hematol.
Belkacemi, Y., Labopin, M., Giebel, S., Gorin, N.Claude, Loganadane, G., Miszczyk, L., Michallet, M., Socié, G., Schaap, N.Pm, Cornelissen, J.J., et al. (2018). Single Dose Daily Fractionated Is Not Inferior To Twice A Day Fractionated Total Body Irradiation Prior To Allogeneic Stem Cell Transplantation For Acute Leukemia: A Useful Practice Simplification Resulting From The Sarasin Study.Int J Radiat Oncol Biol Phys.